136 related articles for article (PubMed ID: 33202736)
1. Effects of the Minimal Extrathyroidal Extension on Early Response Rates after (Adjuvant) Initial Radioactive Iodine Therapy in PTC Patients.
Ahmaddy F; Wenter V; Ilhan H; Wacker D; Unterrainer M; Knösel T; Bartenstein P; Spitzweg C; Lehner S; Todica A
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33202736
[TBL] [Abstract][Full Text] [Related]
2. Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4).
Forleo R; Grani G; Alfò M; Zilioli V; Giubbini R; Zatelli MC; Gagliardi I; Piovesan A; Ragni A; Morelli S; Puxeddu E; Pagano L; Deandrea M; Ceresini G; Torlontano M; Puligheddu B; Antonelli A; Centanni M; Fugazzola L; Spiazzi G; Monti S; Rossetto R; Monzani F; Tallini G; Crescenzi A; Sparano C; Bruno R; Repaci A; Tumino D; Pezzullo L; Lombardi CP; Ferraro Petrillo U; Filetti S; Durante C; Castagna MG
Thyroid; 2021 Dec; 31(12):1814-1821. PubMed ID: 34541894
[No Abstract] [Full Text] [Related]
3. UNFAVORABLE RESPONSES TO RADIOIODINE THERAPY IN N1B PAPILLARY THYROID CANCER: A PROPENSITY SCORE MATCHING STUDY.
Liu YQ; Li H; Liu JR; Lin YS
Endocr Pract; 2019 Dec; 25(12):1286-1294. PubMed ID: 31412228
[No Abstract] [Full Text] [Related]
4. Is There a Difference Between Minimal and Gross Extension into the Strap Muscles for the Risk of Recurrence in Papillary Thyroid Carcinomas?
Danilovic DLS; Castroneves LA; Suemoto CK; Elias LO; Soares IC; Camargo RY; Correa FA; Hoff AO; Marui S
Thyroid; 2020 Jul; 30(7):1008-1016. PubMed ID: 32059626
[No Abstract] [Full Text] [Related]
5. Effect of Tumor Size and Minimal Extrathyroidal Extension in Patients with Differentiated Thyroid Cancer.
Tam S; Amit M; Boonsripitayanon M; Busaidy NL; Cabanillas ME; Waguespack SG; Gross ND; Grubbs EG; Williams MD; Lai SY; Sturgis EM; Zafereo ME
Thyroid; 2018 Aug; 28(8):982-990. PubMed ID: 29936892
[TBL] [Abstract][Full Text] [Related]
6. Low-Dose Radioactive Iodine Ablation Is Sufficient in Patients With Small Papillary Thyroid Cancer Having Minor Extrathyroidal Extension and Central Lymph Node Metastasis (T3 N1a).
Seo M; Kim YS; Lee JC; Han MW; Kim ES; Kim KB; Park SH
Clin Nucl Med; 2017 Nov; 42(11):842-846. PubMed ID: 28832376
[TBL] [Abstract][Full Text] [Related]
7. Small papillary thyroid carcinoma with minimal extrathyroidal extension should be managed as ATA low-risk tumor.
Castagna MG; Forleo R; Maino F; Fralassi N; Barbato F; Palmitesta P; Pilli T; Capezzone M; Brilli L; Ciuoli C; Cantara S; Formichi C; Pacini F
J Endocrinol Invest; 2018 Sep; 41(9):1029-1035. PubMed ID: 29470826
[TBL] [Abstract][Full Text] [Related]
8. Correlation of minimal extrathyroidal extension with pathologic features of lymph node metastasis in patients with papillary thyroid carcinoma.
Lee HS; Park C; Kim SW; Park T; Chun BK; Hong JC; Lee KD
J Surg Oncol; 2015 Nov; 112(6):592-6. PubMed ID: 26421594
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Impact of Microscopic Extra-Thyroidal Extension (mETE) on Disease Free Survival in Patients with Papillary Thyroid Carcinoma (PTC).
Bouzehouane N; Roy P; Decaussin-Petrucci M; Bertholon-Grégoire M; Bully C; Perrin A; Lasolle H; Lifante JC; Borson-Chazot F; Bournaud C
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681573
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of minimal extrathyroidal extension in papillary thyroid carcinoma.
Yin DT; Yu K; Lu RQ; Li X; Xu J; Lei M
Medicine (Baltimore); 2016 Dec; 95(52):e5794. PubMed ID: 28033304
[TBL] [Abstract][Full Text] [Related]
11. Risk of recurrence in patients with papillary thyroid carcinoma and minimal extrathyroidal extension not treated with radioiodine.
Rosario PW; Mourão G; Calsolari MR
J Endocrinol Invest; 2019 Jun; 42(6):687-692. PubMed ID: 30353424
[TBL] [Abstract][Full Text] [Related]
12. Implication of minimal extrathyroidal extension as a prognostic factor in papillary thyroid carcinoma.
Shin JH; Ha TK; Park HK; Ahn MS; Kim KH; Bae KB; Kim TH; Choi CS; Kim TK; Bae SK; Kim SH
Int J Surg; 2013; 11(9):944-7. PubMed ID: 23820062
[TBL] [Abstract][Full Text] [Related]
13. Minimal extrathyroid extension in papillary micro carcinoma of the thyroid is an independent risk factor for relapse through lymph node and distant metastases.
Seifert R; Schäfers MA; Heitplatz B; Kerschke L; Riemann B; Noto B
J Nucl Med; 2021 Mar; 62(12):1702-9. PubMed ID: 33771902
[No Abstract] [Full Text] [Related]
14. Inter-Observer Variation in the Pathologic Identification of Minimal Extrathyroidal Extension in Papillary Thyroid Carcinoma.
Su HK; Wenig BM; Haser GC; Rowe ME; Asa SL; Baloch Z; Du E; Faquin WC; Fellegara G; Giordano T; Ghossein R; LiVolsi VA; Lloyd R; Mete O; Ozbek U; Rosai J; Suster S; Thompson LD; Turk AT; Urken ML
Thyroid; 2016 Apr; 26(4):512-7. PubMed ID: 26953223
[TBL] [Abstract][Full Text] [Related]
15. Low-Activity Radioactive Iodine Therapy for Thyroid Carcinomas Exhibiting Nodal Metastases and Extrathyroidal Extension May Lead to Early Disease Recurrence.
Chu KP; Baker S; Zenke J; Morad A; Ghosh S; Morrish DW; McEwan AJBS; Williams DC; Severin D; McMullen TPW
Thyroid; 2018 Jul; 28(7):902-912. PubMed ID: 29742993
[TBL] [Abstract][Full Text] [Related]
16. Clinical response to radioactive iodine therapy for prophylactic central neck dissection is not superior to total thyroidectomy alone in cN0 patients with papillary thyroid cancer.
Lin B; Qiang W; Wenqi Z; Tianyu Y; Lina Z; Bin J
Nucl Med Commun; 2017 Dec; 38(12):1036-1040. PubMed ID: 28953211
[TBL] [Abstract][Full Text] [Related]
17. Radioactive iodine ablation may not decrease the risk of recurrence in intermediate-risk papillary thyroid carcinoma.
Kim SK; Woo JW; Lee JH; Park I; Choe JH; Kim JH; Kim JS
Endocr Relat Cancer; 2016 May; 23(5):367-76. PubMed ID: 26917553
[TBL] [Abstract][Full Text] [Related]
18. The role of radioactive iodine therapy in papillary thyroid cancer: an observational study based on SEER.
Tang J; Kong D; Cui Q; Wang K; Zhang D; Liao X; Gong Y; Wu G
Onco Targets Ther; 2018; 11():3551-3560. PubMed ID: 29950860
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Curative Effect and Influencing Factors of N1 Stage Papillary Thyroid Micro-Carcinoma and Papillary Thyroid Non-Micro Carcinoma After Initial Radioactive Iodine Ablation Therapy.
Yun C; Wu M; Xiao J; Liu Y; Zhang W; Cao J
Cancer Manag Res; 2021; 13():1427-1434. PubMed ID: 33613032
[TBL] [Abstract][Full Text] [Related]
20. Papillary thyroid cancer: factors involved in restaging N1 disease after total thyroidectomy and radioactive iodine treatment.
Guy A; Hirsch D; Shohat T; Bachar G; Tirosh A; Robenshtok E; Shimon I; Benbassat CA
J Clin Endocrinol Metab; 2014 Nov; 99(11):4167-73. PubMed ID: 25157544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
